CHIEF MEDICAL EDITOR'S PAGE
By Takao Ohki, MD, PhD, Chief Medical Editor
CODING AND REIMBURSEMENT
The Society of Interventional Radiology's position on the current CMS coverage of renal interventions.
By David Sacks, MD, and Timothy P. Murphy, MD
Using percutaneous transhepatic thrombectomy and pharmacological thrombolysis to treat this highly morbid condition.
By Wei Zhou, MD; Tam T. Huynh, MD; and Peter H. Lin, MD
A case report demonstrating the use of this novel technique.
By Mark W. Moritz, MD, FACS, and Michael Ombrellino, MD, FACS
Discerning endpoints for clinical trials in endovascular therapy for infrainguinal arterial disease.
By Michael R. Jaff, DO
An interview with TASC II Co-Chair Lars Norgren, MD, PhD, FRCS, regarding the recently updated and published recommendations.
By TASC II Co-Chair Lars Norgren, MD, PhD, FRCS
Krishna Rocha-Singh, MD, of VIVA Physicians, Inc., discusses their effort to determine nitinol stenting performance goals, collaboration with the FDA and industry, and how clinicians can apply these standards to their practices.
By Krishna Rocha-Singh, MD
An interview with Jennifer Goode of the FDA.
By Jennifer Goode
What is the embolic risk for endovascular SFA intervention? When is embolic protection necessary?
By Michael Wholey, MD, MBA; William C.L. Wu, MD; Boulos Toursarkissian, MD; Raj Suri, MD; Marco Cura, MD; and Martin G. Radvany, MD
A summary of the barriers, unanswered questions, and potential benefits of this technology.
By H. Bob Smouse, MD
A leader in structural heart repair discusses cardiologists' increased role in the periphery, his multidisciplinary practice, and the EVEREST trial.